nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in understanding and reducing the burden of severe asthma in children
|
Pijnenburg, Mariëlle W |
|
|
8 |
10 |
p. 1032-1044 |
artikel |
2 |
A new once-daily long-acting β2-adrenoceptor agonist–inhaled corticosteroid combination therapy for asthma
|
Brusselle, Guy |
|
|
8 |
10 |
p. 936-937 |
artikel |
3 |
Apples and oranges: international comparisons of COVID-19 observational studies in ICUs
|
Millar, Jonathan E |
|
|
8 |
10 |
p. 952-953 |
artikel |
4 |
Assessing the benefits of triple versus dual fixed-dose combinations for the treatment of severe asthma
|
Virchow, J Christian |
|
|
8 |
10 |
p. 937-939 |
artikel |
5 |
A threat to decentralised care for drug-resistant tuberculosis
|
Gray, Adam T |
|
|
8 |
10 |
p. 950-952 |
artikel |
6 |
COPD exacerbations: finally, a more than ACCEPTable risk score
|
Bhatt, Surya P |
|
|
8 |
10 |
p. 939-941 |
artikel |
7 |
Correction to Lancet Respir Med 2020; 8: 963–74
|
|
|
|
8 |
10 |
p. e75 |
artikel |
8 |
COVID-19 and preschool wheeze care: lessons learned
|
Makrinioti, Heidi |
|
|
8 |
10 |
p. 957-959 |
artikel |
9 |
Early-life origins of respiratory diseases: a key to prevention
|
The Lancet Respiratory Medicine, |
|
|
8 |
10 |
p. 935 |
artikel |
10 |
Hypersensitivity pneumonitis: the first diagnostic guidelines
|
Tzilas, Vasilios |
|
|
8 |
10 |
p. 955-957 |
artikel |
11 |
IASLC 2020 World Conference on Lung Cancer
|
Venkatesan, Priya |
|
|
8 |
10 |
p. e76 |
artikel |
12 |
Immunotherapies for COVID-19: lessons learned from sepsis
|
Remy, Kenneth E |
|
|
8 |
10 |
p. 946-949 |
artikel |
13 |
Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial
|
Man, Wing Ho |
|
|
8 |
10 |
p. 1022-1031 |
artikel |
14 |
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
|
Hewer, Simon C Langton |
|
|
8 |
10 |
p. 975-986 |
artikel |
15 |
Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient
|
Lang, Christian |
|
|
8 |
10 |
p. 1057-1060 |
artikel |
16 |
Mariëlle Pijnenburg: solving the puzzle of asthma
|
Kirby, Tony |
|
|
8 |
10 |
p. 961-962 |
artikel |
17 |
Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study
|
van Zyl-Smit, Richard N |
|
|
8 |
10 |
p. 987-999 |
artikel |
18 |
Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
|
Kerstjens, Huib A M |
|
|
8 |
10 |
p. 1000-1012 |
artikel |
19 |
Patient support groups are a lifeline for those with idiopathic pulmonary fibrosis
|
Almond, Howard |
|
|
8 |
10 |
p. 959-961 |
artikel |
20 |
Pollen count data and respiratory diseases in South Africa
|
Makoni, Munyaradzi |
|
|
8 |
10 |
p. e77 |
artikel |
21 |
Reducing the burden of asthma: time to set research and clinical priorities
|
Beasley, Richard |
|
|
8 |
10 |
p. 943-944 |
artikel |
22 |
Respiratory syncytial virus treatment and the respiratory microbiome
|
Mejias, Asuncion |
|
|
8 |
10 |
p. 941-943 |
artikel |
23 |
Serological assays for delayed SARS-CoV-2 case identification
|
Choy, Kay Weng |
|
|
8 |
10 |
p. e73 |
artikel |
24 |
Serological assays for delayed SARS-CoV-2 case identification – Author's reply
|
Pallett, Scott J C |
|
|
8 |
10 |
p. e74 |
artikel |
25 |
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study
|
Adibi, Amin |
|
|
8 |
10 |
p. 1013-1021 |
artikel |
26 |
The genetics of asthma and the promise of genomics-guided drug target discovery
|
El-Husseini, Zaid W |
|
|
8 |
10 |
p. 1045-1056 |
artikel |
27 |
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
|
Khanna, Dinesh |
|
|
8 |
10 |
p. 963-974 |
artikel |
28 |
Use of facemasks during the COVID-19 pandemic
|
Schünemann, Holger J |
|
|
8 |
10 |
p. 954-955 |
artikel |
29 |
When to consider lung transplantation for COVID-19
|
Cypel, Marcelo |
|
|
8 |
10 |
p. 944-946 |
artikel |